Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 6/20 | 0.81 |
| ▸ | P2RX2 | Q9UBL9 | 6/20 | 0.81 |
| ▸ | DHFR | P00374 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30215812 | 0.90 | P2RX3 (1.00) | P2RX3P2RX2DHFRMEN1SLC22A1 | |
| SCHEMBL29384647 | 0.90 | P2RX3 (1.00) | P2RX3P2RX2DHFRMEN1SLC22A1 | |
| SCHEMBL1494010 | 0.90 | P2RX3 (1.00) | P2RX3P2RX2DHFRMEN1SLC22A1 | |
| SCHEMBL30215930 | 0.86 | P2RX3 (0.83) | P2RX3P2RX2DHFRMEN1SLC22A1 | |
| SCHEMBL1493830 | 0.86 | P2RX3 (0.83) | P2RX3P2RX2DHFRMEN1SLC22A1 | |
| SCHEMBL1493822 | 0.85 | P2RX3 (0.90) | P2RX3P2RX2DHFRHTT | |
| SCHEMBL30215918 | 0.85 | P2RX3 (0.81) | P2RX3P2RX2 | |
| SCHEMBL1493880 | 0.85 | P2RX3 (0.81) | P2RX3P2RX2 | |
| SCHEMBL20646269 | 0.85 | P2RX3 (0.81) | P2RX3P2RX2 | |
| SCHEMBL30215753 | 0.85 | P2RX3 (0.90) | P2RX3P2RX2DHFRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2343282-B1 | Diaminopyrimidines as P2X3 and P2X2/3 antagonists | HOFFMANN LA ROCHE (CH) | 2015-07-22 | — | — | EP | claimed |
| EP-2343282-B1 | Diaminopyrimidines as P2X3 and P2X2/3 antagonists | HOFFMANN LA ROCHE (CH) | 2015-07-22 | — | — | EP | disclosed |
| EP-2343282-A1 | Diaminopyrimidines as P2X3 and P2X2/3 antagonists | F. Hoffmann-La Roche AG (CH) | 2011-07-13 | — | — | EP | disclosed |
| EP-1725540-A1 | DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS | F.HOFFMANN-LA ROCHE AG (CH) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005095359-A1 | DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2005-10-13 | — | — | WO | disclosed |